Experimental drug shrinks advanced kidney cancer tumors, clears disease in one patient (2026, May 14) retrieved 14 May 2026 from https://medicalxpress.com/news/2026-05-experimental-drug-advanced-kidney-tumors.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission.
The liver's immune cells might be the key to curing hepatitis B 20 hours ago Gene-edited stem cell transplant shows promise for aggressive blood cancers May 12, 2026 Caffeine may influence the way the brain responds to touch May 11, 2026 Brain-controlled hearing system isolates one speaker in noisy settings, first human tests show May 11, 2026 Too little sleep— and too much —associated with faster aging May 13, 2026 Dinner at the door: Convenient healthy meals may ease depression symptoms 32 minutes ago
How understanding art history can help doctors treat obesity 55 minutes ago Friendly skin bacteria shut down inflammatory driver of eczema 2 hours ago Heart disease risk may start in the womb 2 hours ago Rare kidney cancer resists immune therapies due to lack of active T-cells Jan 9, 2025 Genetic analysis links immune cell profiles to kidney cancer therapy outcomes Feb 28, 2025 Belzutifan+pembrolizumab post-surgery helps kidney cancer patients at high risk for relapse stay cancer-free longer Mar 2, 2026
Mechanism behind immunotherapy resistance in lung cancer identified Feb 19, 2026 Molecular subtypes of advanced kidney cancer matter for treatment response Apr 5, 2024
